Austrianova announces German subsidiary and new location in Singapore
SG Austria (“Austrianova”), a leading provider of cell encapsulation, has established a German subsidiary in Munich and moved to a new location in Singapore.
SINGAPORE, October 31, 2023 /EINPresswire.com/ — SG Austria (“Austrianova”), a leading provider of cell biological products and services, today announced that it has established a German subsidiary company based in Munich and moved to a new location in Singapore.
The German subsidiary, Austrianova Germany, at “Am Klopferspitz” in Martinsried, the world renowned German biotech centre, will function as Austrianova’s European base, expanding the company’s activities and reach.
In August the company also moved to a new location in Singapore at “The Strategy” located in the International Business Park at Jurong, Singapore’s new business district. This facility functions as the company’s headquarters as well as being its Bac-in-a-Box® research facility and was made possible by an additional investment into the company by the US and Korea-based life sciences investment firm Checkmate Capital which has a special focus on cross-border transactions in Asia.
Read the full article here: Austrianova announces German subsidiary and new location in Singapore (einpresswire.com)
This release includes forward-looking statements regarding Austrianova / SGAustria (the Company) and its respective businesses. Such statements are based on the current expectations of the management of each entity. The forward-looking events and circumstances discussed in this release may not occur and could differ materially as a result of known and unknown risk factors and uncertainties affecting the Company, including risks from economic factors and the equity markets generally. No forward-looking statement can be guaranteed. Except as required by applicable securities laws, forward-looking statements speak only as of the date on which they are made and Austrianova undertakes no obligation to publicly up-date or revise any forward-looking statement, whether as a result of new information, future events, or otherwise. This is not an offer or solicitation to buy or sell any securities.
Financial Information Contact: email@example.com
Company and Technology Contact: firstname.lastname@example.org
For more information: http://www.austrianova.com
email us here